Global Epilepsy Surgery Market

Epilepsy Surgery Comprehensive Study by Surgery Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT), Deep brain stimulation, Corpus callosotomy, Hemispherectomy, Functional hemispherectomy), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals & Clinics, Specialty Centers) Players and Region - Global Market Outlook to 2032

Epilepsy Surgery Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Epilepsy Surgery
Epilepsy surgery is a consideration for patients with drug-resistant epilepsy, where seizures cannot be controlled by conventional medicine. It is performed when seizure occurrences seriously interrupt the quality of life, and other treatments have not helped. The aimed purpose of epilepsy surgery is to remove two different portions or to alter one part of the brain, which instigates seizures, so the patient can have a long-term future free from seizures and live a more fulfilling life in general. A broad battery of tests may be conducted before surgery. Apart from imaging techniques like MRI and functional imaging for localization of seizure activity, usually patients may also have whatever detailed information they will from the focus of their seizures. There are some occasions that electrocorticography or long-term video-EEG monitoring is needed to gather information about the seizure focus. In some rare cases, invasive monitoring with implanted electrodes is necessary to accurately localize the seizures. Once a focus based on the predetermined goal is defined, it may elect to execute either colobectomy, focal resection, or exlusively other less invasive procedures, namely laser ablation. Responsive neuro-stimulation is implantation of a device, which delivers electrical stimulation on concern of the development of a seizure. Epilepsy surgery can bring significant advantages to the lives of many, including seizure freedom or less frequent seizure occurrences. That being said, there are some risks involved in surgery, including cognitive and neurological side effects, which are weighed up against the benefits during a decision-making process.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Stryker (US), Zimmer Biomet Holdings Inc. (US), Auris Health Inc. (Hansen Medical Inc.) (US), Intuitive Surgical (US), Medtronic Plc (Mazor Robotics) (Ireland), Cephalon Inc (US), CMR Surgical (UK), Natus Medical Incorporated (US), Livanova Plc (UK) and Monteris Medical (US) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Epilepsy Surgery market by and Region.



On the basis of geography, the market of Epilepsy Surgery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Surgery Type, the sub-segment i.e. Respective Surgery will boost the Epilepsy Surgery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Age Group, the sub-segment i.e. Pediatric will boost the Epilepsy Surgery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals & Clinics will boost the Epilepsy Surgery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Personalized Epilepsy Surgery and Leveraging telemedicine platforms for remote patient monitoring and follow-up care.

Market Growth Drivers:
Continuous innovations in surgical techniques and technologies enhance treatment outcomes and patient safety. and The growing number of epilepsy cases worldwide fuels the demand for surgical interventions.

Challenges:
Post-surgical monitoring is necessary to assess treatment effectiveness and manage potential complications.

Restraints:
Epilepsy surgery can be expensive, limiting accessibility for some patients. and Despite advances in techniques, surgical interventions carry inherent risks, including infection and neurological deficits.

Opportunities:
The development of more sophisticated imaging technologies like high-definition functional MRI, positron emission tomography (PET), and magnetoencephalography (MEG),

Market Leaders and their expansionary development strategies
In October 2022, NHS launched laser beam brain surgery to treat epilepsy, Offering hope to thousands of current and future NHS patients, the cutting-edge laser treatment, targets the part of the brain that is causing the seizures without the need for invasive surgery.
In February 2023, Aster Medcity launched the new Pediatric Epilepsy Centre, offering cutting-edge treatments and services for children with epilepsy. The Centre will provide all-inclusive care, including the latest medical treatments, diagnostic services, support programs, and specialized pediatric surgeries for children with epilepsy. Mayor- Emirati Councillor Tom Aditya, Leader and Spokesperson of Bristol- Bradley Stoke Council inaugurated the centre.


Key Target Audience
Manufacturers Suppliers and Distributors, Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Government Regulatory, Research Organizations, End-Use Industries and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Surgery Type
  • Respective Surgery
  • Laser Interstitial Thermal Therapy (LITT)
  • Deep brain stimulation
  • Corpus callosotomy
  • Hemispherectomy
  • Functional hemispherectomy

By Age Group
  • Pediatric
  • Adult
  • Geriatric

By End User
  • Hospitals & Clinics
  • Specialty Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Continuous innovations in surgical techniques and technologies enhance treatment outcomes and patient safety.
      • 3.2.2. The growing number of epilepsy cases worldwide fuels the demand for surgical interventions.
    • 3.3. Market Challenges
      • 3.3.1. Post-surgical monitoring is necessary to assess treatment effectiveness and manage potential complications.
    • 3.4. Market Trends
      • 3.4.1. Personalized Epilepsy Surgery
      • 3.4.2. Leveraging telemedicine platforms for remote patient monitoring and follow-up care.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Epilepsy Surgery, by Surgery Type, Age Group, End User and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Epilepsy Surgery (Value)
      • 5.2.1. Global Epilepsy Surgery by: Surgery Type (Value)
        • 5.2.1.1. Respective Surgery
        • 5.2.1.2. Laser Interstitial Thermal Therapy (LITT)
        • 5.2.1.3. Deep brain stimulation
        • 5.2.1.4. Corpus callosotomy
        • 5.2.1.5. Hemispherectomy
        • 5.2.1.6. Functional hemispherectomy
      • 5.2.2. Global Epilepsy Surgery by: Age Group (Value)
        • 5.2.2.1. Pediatric
        • 5.2.2.2. Adult
        • 5.2.2.3. Geriatric
      • 5.2.3. Global Epilepsy Surgery by: End User (Value)
        • 5.2.3.1. Hospitals & Clinics
        • 5.2.3.2. Specialty Centers
      • 5.2.4. Global Epilepsy Surgery Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Epilepsy Surgery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Stryker (US)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Zimmer Biomet Holdings Inc. (US)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Auris Health Inc. (Hansen Medical Inc.) (US)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Intuitive Surgical (US)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medtronic Plc (Mazor Robotics) (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cephalon Inc (US)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. CMR Surgical (UK)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Natus Medical Incorporated (US)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Livanova Plc (UK)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Monteris Medical (US)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Epilepsy Surgery Sale, by Surgery Type, Age Group, End User and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Epilepsy Surgery (Value)
      • 7.2.1. Global Epilepsy Surgery by: Surgery Type (Value)
        • 7.2.1.1. Respective Surgery
        • 7.2.1.2. Laser Interstitial Thermal Therapy (LITT)
        • 7.2.1.3. Deep brain stimulation
        • 7.2.1.4. Corpus callosotomy
        • 7.2.1.5. Hemispherectomy
        • 7.2.1.6. Functional hemispherectomy
      • 7.2.2. Global Epilepsy Surgery by: Age Group (Value)
        • 7.2.2.1. Pediatric
        • 7.2.2.2. Adult
        • 7.2.2.3. Geriatric
      • 7.2.3. Global Epilepsy Surgery by: End User (Value)
        • 7.2.3.1. Hospitals & Clinics
        • 7.2.3.2. Specialty Centers
      • 7.2.4. Global Epilepsy Surgery Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Epilepsy Surgery: by Surgery Type(USD Million)
  • Table 2. Epilepsy Surgery Respective Surgery , by Region USD Million (2019-2024)
  • Table 3. Epilepsy Surgery Laser Interstitial Thermal Therapy (LITT) , by Region USD Million (2019-2024)
  • Table 4. Epilepsy Surgery Deep brain stimulation , by Region USD Million (2019-2024)
  • Table 5. Epilepsy Surgery Corpus callosotomy , by Region USD Million (2019-2024)
  • Table 6. Epilepsy Surgery Hemispherectomy , by Region USD Million (2019-2024)
  • Table 7. Epilepsy Surgery Functional hemispherectomy , by Region USD Million (2019-2024)
  • Table 8. Epilepsy Surgery: by Age Group(USD Million)
  • Table 9. Epilepsy Surgery Pediatric , by Region USD Million (2019-2024)
  • Table 10. Epilepsy Surgery Adult , by Region USD Million (2019-2024)
  • Table 11. Epilepsy Surgery Geriatric , by Region USD Million (2019-2024)
  • Table 12. Epilepsy Surgery: by End User(USD Million)
  • Table 13. Epilepsy Surgery Hospitals & Clinics , by Region USD Million (2019-2024)
  • Table 14. Epilepsy Surgery Specialty Centers , by Region USD Million (2019-2024)
  • Table 15. South America Epilepsy Surgery, by Country USD Million (2019-2024)
  • Table 16. South America Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 17. South America Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 18. South America Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 19. Brazil Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 20. Brazil Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 21. Brazil Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 22. Argentina Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 23. Argentina Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 24. Argentina Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 25. Rest of South America Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 26. Rest of South America Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 27. Rest of South America Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 28. Asia Pacific Epilepsy Surgery, by Country USD Million (2019-2024)
  • Table 29. Asia Pacific Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 30. Asia Pacific Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 31. Asia Pacific Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 32. China Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 33. China Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 34. China Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 35. Japan Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 36. Japan Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 37. Japan Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 38. India Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 39. India Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 40. India Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 41. South Korea Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 42. South Korea Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 43. South Korea Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 44. Taiwan Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 45. Taiwan Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 46. Taiwan Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 47. Australia Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 48. Australia Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 49. Australia Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 50. Rest of Asia-Pacific Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 51. Rest of Asia-Pacific Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 52. Rest of Asia-Pacific Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 53. Europe Epilepsy Surgery, by Country USD Million (2019-2024)
  • Table 54. Europe Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 55. Europe Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 56. Europe Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 57. Germany Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 58. Germany Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 59. Germany Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 60. France Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 61. France Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 62. France Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 63. Italy Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 64. Italy Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 65. Italy Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 66. United Kingdom Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 67. United Kingdom Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 68. United Kingdom Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 69. Netherlands Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 70. Netherlands Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 71. Netherlands Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 72. Rest of Europe Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 73. Rest of Europe Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 74. Rest of Europe Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 75. MEA Epilepsy Surgery, by Country USD Million (2019-2024)
  • Table 76. MEA Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 77. MEA Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 78. MEA Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 79. Middle East Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 80. Middle East Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 81. Middle East Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 82. Africa Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 83. Africa Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 84. Africa Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 85. North America Epilepsy Surgery, by Country USD Million (2019-2024)
  • Table 86. North America Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 87. North America Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 88. North America Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 89. United States Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 90. United States Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 91. United States Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 92. Canada Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 93. Canada Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 94. Canada Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 95. Mexico Epilepsy Surgery, by Surgery Type USD Million (2019-2024)
  • Table 96. Mexico Epilepsy Surgery, by Age Group USD Million (2019-2024)
  • Table 97. Mexico Epilepsy Surgery, by End User USD Million (2019-2024)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Epilepsy Surgery: by Surgery Type(USD Million)
  • Table 109. Epilepsy Surgery Respective Surgery , by Region USD Million (2027-2032)
  • Table 110. Epilepsy Surgery Laser Interstitial Thermal Therapy (LITT) , by Region USD Million (2027-2032)
  • Table 111. Epilepsy Surgery Deep brain stimulation , by Region USD Million (2027-2032)
  • Table 112. Epilepsy Surgery Corpus callosotomy , by Region USD Million (2027-2032)
  • Table 113. Epilepsy Surgery Hemispherectomy , by Region USD Million (2027-2032)
  • Table 114. Epilepsy Surgery Functional hemispherectomy , by Region USD Million (2027-2032)
  • Table 115. Epilepsy Surgery: by Age Group(USD Million)
  • Table 116. Epilepsy Surgery Pediatric , by Region USD Million (2027-2032)
  • Table 117. Epilepsy Surgery Adult , by Region USD Million (2027-2032)
  • Table 118. Epilepsy Surgery Geriatric , by Region USD Million (2027-2032)
  • Table 119. Epilepsy Surgery: by End User(USD Million)
  • Table 120. Epilepsy Surgery Hospitals & Clinics , by Region USD Million (2027-2032)
  • Table 121. Epilepsy Surgery Specialty Centers , by Region USD Million (2027-2032)
  • Table 122. South America Epilepsy Surgery, by Country USD Million (2027-2032)
  • Table 123. South America Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 124. South America Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 125. South America Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 126. Brazil Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 127. Brazil Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 128. Brazil Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 129. Argentina Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 130. Argentina Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 131. Argentina Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 132. Rest of South America Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 133. Rest of South America Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 134. Rest of South America Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 135. Asia Pacific Epilepsy Surgery, by Country USD Million (2027-2032)
  • Table 136. Asia Pacific Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 137. Asia Pacific Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 138. Asia Pacific Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 139. China Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 140. China Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 141. China Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 142. Japan Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 143. Japan Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 144. Japan Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 145. India Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 146. India Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 147. India Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 148. South Korea Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 149. South Korea Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 150. South Korea Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 151. Taiwan Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 152. Taiwan Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 153. Taiwan Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 154. Australia Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 155. Australia Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 156. Australia Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 157. Rest of Asia-Pacific Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 158. Rest of Asia-Pacific Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 159. Rest of Asia-Pacific Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 160. Europe Epilepsy Surgery, by Country USD Million (2027-2032)
  • Table 161. Europe Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 162. Europe Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 163. Europe Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 164. Germany Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 165. Germany Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 166. Germany Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 167. France Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 168. France Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 169. France Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 170. Italy Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 171. Italy Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 172. Italy Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 173. United Kingdom Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 174. United Kingdom Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 175. United Kingdom Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 176. Netherlands Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 177. Netherlands Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 178. Netherlands Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 179. Rest of Europe Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 180. Rest of Europe Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 181. Rest of Europe Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 182. MEA Epilepsy Surgery, by Country USD Million (2027-2032)
  • Table 183. MEA Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 184. MEA Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 185. MEA Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 186. Middle East Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 187. Middle East Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 188. Middle East Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 189. Africa Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 190. Africa Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 191. Africa Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 192. North America Epilepsy Surgery, by Country USD Million (2027-2032)
  • Table 193. North America Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 194. North America Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 195. North America Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 196. United States Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 197. United States Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 198. United States Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 199. Canada Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 200. Canada Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 201. Canada Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 202. Mexico Epilepsy Surgery, by Surgery Type USD Million (2027-2032)
  • Table 203. Mexico Epilepsy Surgery, by Age Group USD Million (2027-2032)
  • Table 204. Mexico Epilepsy Surgery, by End User USD Million (2027-2032)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Epilepsy Surgery: by Surgery Type USD Million (2019-2024)
  • Figure 5. Global Epilepsy Surgery: by Age Group USD Million (2019-2024)
  • Figure 6. Global Epilepsy Surgery: by End User USD Million (2019-2024)
  • Figure 7. South America Epilepsy Surgery Share (%), by Country
  • Figure 8. Asia Pacific Epilepsy Surgery Share (%), by Country
  • Figure 9. Europe Epilepsy Surgery Share (%), by Country
  • Figure 10. MEA Epilepsy Surgery Share (%), by Country
  • Figure 11. North America Epilepsy Surgery Share (%), by Country
  • Figure 12. Global Epilepsy Surgery share by Players 2024 (%)
  • Figure 13. Global Epilepsy Surgery share by Players (Top 3) 2024(%)
  • Figure 14. Global Epilepsy Surgery share by Players (Top 5) 2024(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Stryker (US) Revenue, Net Income and Gross profit
  • Figure 17. Stryker (US) Revenue: by Geography 2024
  • Figure 18. Zimmer Biomet Holdings Inc. (US) Revenue, Net Income and Gross profit
  • Figure 19. Zimmer Biomet Holdings Inc. (US) Revenue: by Geography 2024
  • Figure 20. Auris Health Inc. (Hansen Medical Inc.) (US) Revenue, Net Income and Gross profit
  • Figure 21. Auris Health Inc. (Hansen Medical Inc.) (US) Revenue: by Geography 2024
  • Figure 22. Intuitive Surgical (US) Revenue, Net Income and Gross profit
  • Figure 23. Intuitive Surgical (US) Revenue: by Geography 2024
  • Figure 24. Medtronic Plc (Mazor Robotics) (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Medtronic Plc (Mazor Robotics) (Ireland) Revenue: by Geography 2024
  • Figure 26. Cephalon Inc (US) Revenue, Net Income and Gross profit
  • Figure 27. Cephalon Inc (US) Revenue: by Geography 2024
  • Figure 28. CMR Surgical (UK) Revenue, Net Income and Gross profit
  • Figure 29. CMR Surgical (UK) Revenue: by Geography 2024
  • Figure 30. Natus Medical Incorporated (US) Revenue, Net Income and Gross profit
  • Figure 31. Natus Medical Incorporated (US) Revenue: by Geography 2024
  • Figure 32. Livanova Plc (UK) Revenue, Net Income and Gross profit
  • Figure 33. Livanova Plc (UK) Revenue: by Geography 2024
  • Figure 34. Monteris Medical (US) Revenue, Net Income and Gross profit
  • Figure 35. Monteris Medical (US) Revenue: by Geography 2024
  • Figure 36. Global Epilepsy Surgery: by Surgery Type USD Million (2027-2032)
  • Figure 37. Global Epilepsy Surgery: by Age Group USD Million (2027-2032)
  • Figure 38. Global Epilepsy Surgery: by End User USD Million (2027-2032)
  • Figure 39. South America Epilepsy Surgery Share (%), by Country
  • Figure 40. Asia Pacific Epilepsy Surgery Share (%), by Country
  • Figure 41. Europe Epilepsy Surgery Share (%), by Country
  • Figure 42. MEA Epilepsy Surgery Share (%), by Country
  • Figure 43. North America Epilepsy Surgery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Stryker (US)
  • Zimmer Biomet Holdings Inc. (US)
  • Auris Health Inc. (Hansen Medical Inc.) (US)
  • Intuitive Surgical (US)
  • Medtronic Plc (Mazor Robotics) (Ireland)
  • Cephalon Inc (US)
  • CMR Surgical (UK)
  • Natus Medical Incorporated (US)
  • Livanova Plc (UK)
  • Monteris Medical (US)
Select User Access Type

Key Highlights of Report


Jan 2025 211 Pages 71 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Epilepsy Surgery Market Quantitative research analysis
Global Epilepsy Surgery Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Stryker (US), Zimmer Biomet Holdings Inc. (US), Auris Health Inc. (Hansen Medical Inc.) (US), Intuitive Surgical (US), Medtronic Plc (Mazor Robotics) (Ireland), Cephalon Inc (US), CMR Surgical (UK), Natus Medical Incorporated (US), Livanova Plc (UK) and Monteris Medical (US) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Personalized Epilepsy Surgery " is seen as one of major influencing trends for Epilepsy Surgery Market during projected period 2024-2032.
The Epilepsy Surgery market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Epilepsy Surgery Market Report?

Have a Query? Click Here

Other Related Reports

Antibody Drug Discovery Comprehensive Study by Application (Oncology, Cardiology, Infectious diseases, Autoimmune diseases, Others), Type (Monoclonal antibodies, Polyclonal antibodies, Bispecific ant...
$ 3800
Soft Tissue Sarcoma Comprehensive Study by Type (Liposarcoma, Leiomyosarcoma, Synovial Sarcoma, Fibrosarcomas, Rhabdomyosarcoma, Gastrointestinal Stromal Tumor (GIST), Epithelioid Sarcoma, Others), E...
$ 3800
Digestive Health Supplements Market Comprehensive Study by Type (Prebiotics, Probiotics, Enzymes, Other), Form (Capsules, Tablets, Powder, Liquid, Soft Gels, Others), Distribution Channel (Hypermarke...
$ 3800
Veterinary Hospital Comprehensive Study by Ownership (Private, Public), Animal Type (Companion Animals, Farm Animals), Service Type (Surgical Veterinary services, Diagnostic Services, Consultation Se...
$ 3800
Healthcare Payer & Healthcare Providers Comprehensive Study by Type (Payers Outlook, Public Payers (Medicare, Medicaid), Private Payers (Health Maintenance Organizations (HMOs), Preferred Provider Or...
$ 3800
Veterinary API Comprehensive Study by Type (Parasiticides, Anti-inflammatory, Antimicrobials, Vaccines, Hormones, Others), Route of Administration (Oral, Injectable, Topical, Others), Synthesis Type ...
$ 3800